AAAAAA
Results:
1-11
|
Results: 11
Authors:
Catalano, V
Baldelli, AM
Giordani, P
Cascinu, S
Citation: V. Catalano et al., Molecular markers predictive of response to chemotherapy in gastrointestinal tumors, CR R ONC H, 38(2), 2001, pp. 93-104
Authors:
Cascinu, S
Graziano, F
Valentini, M
Catalano, V
Giordani, P
Staccioli, MP
Rossi, C
Baldelli, AM
Grianti, C
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: Relationships with tumor recurrence and resistance to adjuvant chemotherapy, ANN ONCOL, 12(2), 2001, pp. 239-244
Authors:
Cascinu, S
Graziano, F
Catalano, V
Staccioli, MP
Barni, S
Giordani, P
Rossi, MC
Baldelli, AM
Muretto, P
Valenti, A
Catalano, G
Citation: S. Cascinu et al., Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors, CLIN EXP M, 18(8), 2001, pp. 651-655
Authors:
Cascinu, S
Catalano, V
Giordani, P
Baldelli, AM
Agostinelli, R
Catalano, G
Citation: S. Cascinu et al., Gastrointestinal cancer refractory to chemotherapy: A role for octreotide?, CHEMOTHERA, 47, 2001, pp. 127-133
Authors:
Cascinu, S
Graziano, F
Barni, S
Labianca, R
Comella, G
Casaretti, R
Frontini, L
Catalano, V
Baldelli, AM
Catalano, G
Citation: S. Cascinu et al., A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer, BR J CANC, 84(4), 2001, pp. 470-474
Authors:
Cascinu, S
Staccioli, MP
Gasparini, G
Giordani, P
Catalano, V
Ghiselli, R
Rossi, C
Baldelli, AM
Graziano, F
Saba, V
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer, CLIN CANC R, 6(7), 2000, pp. 2803-2807
Authors:
Cascinu, S
Catalano, V
Aschele, C
Barni, S
Debernardis, D
Gallo, L
Bandelloni, R
Staccioli, MP
Baldelli, AM
Brenna, A
Valenti, A
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Immunohistochemical determination of p53 protein does not predict clinicalresponse in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination, ANN ONCOL, 11(8), 2000, pp. 1053-1056
Authors:
Graziano, F
Catalano, V
Baldelli, AM
Giordani, P
Testa, E
Lai, V
Catalano, G
Battelli, N
Cascinu, S
Citation: F. Graziano et al., A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer, ANN ONCOL, 11(10), 2000, pp. 1263-1266
Authors:
Mosconi, S
Cascinu, S
Zaniboni, A
Catalano, V
Giordani, P
Beretta, GD
Martignoni, G
Pancera, G
Baldelli, AM
Poletti, P
Curti, C
Labianca, R
Citation: S. Mosconi et al., The value of oxaliplatin in combination with continuous infusion +/- bolus5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: A GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial, TUMORI, 86(6), 2000, pp. 465-469
Authors:
Cascinu, S
Graziano, F
Catalano, V
Valentini, M
Rossi, MC
Baldelli, AM
Ghiselli, R
Saba, V
Giordani, P
Catalano, G
Citation: S. Cascinu et al., Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy, ANTICANC R, 20(5C), 2000, pp. 3839-3842
Authors:
Cascinu, S
Silva, RR
Labianca, R
Barni, S
Mattioli, R
Martignoni, G
Frontini, L
Gasparini, G
Catalano, V
Baldelli, AM
Giuliodori, L
Agostinelli, R
Catalano, G
Citation: S. Cascinu et al., A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer, ANN ONCOL, 10(8), 1999, pp. 985-987
Risultati:
1-11
|